Synthesis of bivalent β2-adrenergic and adenosine A1 receptor ligands

被引:25
|
作者
Karellas, Peter [2 ,3 ]
McNaughton, Michael [2 ]
Baker, Stephen P. [1 ]
Scammells, Peter J. [2 ]
机构
[1] Univ Florida, Coll Med, Dept Pharmacol & Therapeut, Gainesville, FL 32610 USA
[2] Monash Univ, Monash Inst Pharmaceut Sci, Parkville, Vic 3052, Australia
[3] Starpharma Pty Ltd, Melbourne, Vic, Australia
关键词
D O I
10.1021/jm800613s
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Research in the area of simutaneously targeting more than one G protein-coupled receptor (GPCR) has increased in recent times. By exploiting the cross talk between the beta(2)-adrenergic (beta(2)AR) and adenosine A(1) receptors (A(1)AR) on adenylate cyclase activity, we synthesized a series of bivalent agonists for both GPCRs to generate responses from more than one receptor. We have demonstrated a relationship between the various beta(2)-adrenergic and A(1) adenosine bivalent parameters of linker and bifunctionality by using data that are drawn from in vitro assays. The hexyl-linked 12e (K-i, 311 nM) and butyl-linked 12c (K-i, 863 nM) bivalent compounds displayed reasonable binding affinities for the PAR when compared with the control (-)isoproterenol (K-i, 136 nM), and both compounds also exhibited a persuasive bifunctional trend for both receptors at various drug concentrations. The bivalent compound 12e was also found to have significant EC50 potency (6 nM) at the beta(2)AR in DDT cells.
引用
收藏
页码:6128 / 6137
页数:10
相关论文
共 50 条
  • [31] Interaction of angiotensin II and adenosine A1 and A2A receptor ligands on the writhing test in mice
    Pechlivanova, DM
    Georgiev, VP
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 2002, 72 (1-2) : 23 - 28
  • [32] Gender differences in the cardiac A1 adenosine receptor anti-adrenergic effect
    McIntosh, Victoria J.
    Chandrasekera, P. Charukeshi
    Lasley, Robert D.
    FASEB JOURNAL, 2010, 24
  • [33] Polymorphisms of the β2-adrenergic receptor.
    Liggett, SB
    NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (07): : 536 - 537
  • [34] β1 and β2-adrenergic receptor polymorphisms and idiopathic ventricular arrhythmias
    Ulucan, Cem
    Cetintas, Vildan
    Tetik, Asli
    Eroglu, Zuhal
    Kayikcioglu, Meral
    Can, Levent H.
    Payzin, Serdar
    Aydin, Mehmet
    Hasdemir, Can
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2008, 19 (10) : 1053 - 1058
  • [35] Probing the Existence of a Metastable Binding Site at the β2-Adrenergic Receptor with Homobivalent Bitopic Ligands
    Gaiser, Birgit I.
    Danielsen, Mia
    Marcher-Rorsted, Emil
    Jorgensen, Kira Ropke
    Wrobel, Tomasz M.
    Frykman, Mikael
    Johansson, Henrik
    Brauner-Osborne, Hans
    Gloriam, David E.
    Mathiesen, Jesper Mosolff
    Pedersen, Daniel Sejer
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (17) : 7806 - 7839
  • [36] Modulation of the cardiac β-adrenergic contractile response by adenosine A1 and A2a receptors: evidence for receptor interactions
    Chandrasekera, P. Charukeshi
    McIntosh, Victoria J.
    Cao, Frank
    Lasley, Robert D.
    FASEB JOURNAL, 2010, 24
  • [37] A1 adenosine receptor antagonist
    Holladay, MW
    DRUG DISCOVERY TODAY, 1998, 3 (05) : 240 - 240
  • [38] Influence of fluorophore and linker composition on the pharmacology of fluorescent adenosine A1 receptor ligands
    Baker, Jillian G.
    Middleton, Richard
    Adams, Luke
    May, Lauren T.
    Briddon, Stephen J.
    Kellam, Barrie
    Hill, Stephen J.
    BRITISH JOURNAL OF PHARMACOLOGY, 2010, 159 (04) : 772 - 786
  • [39] Therapeutic potential of A1 adenosine receptor ligands:: a survey of recent patent literature
    Giorgi, Irene
    Nieri, Paola
    EXPERT OPINION ON THERAPEUTIC PATENTS, 2008, 18 (07) : 677 - 691
  • [40] Agonistic Autoantibodies to the α1-Adrenergic Receptor and the β2-Adrenergic Receptor in Alzheimer's and Vascular Dementia
    Karczewski, P.
    Hempel, P.
    Kunze, R.
    Bimmler, M.
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2012, 75 (05) : 524 - 530